omniture
logo
Search
MOLEAC PTE LTD
Media Room

Latest News

rss

Moleac Announces PT Ferron Par Pharmaceuticals as New Exclusive Partner in Indonesia

SINGAPORE, Oct. 21, 2024 /PRNewswire/ -- Moleac is excited to announce a significant milestone in t...

2024-10-21 22:20 1761

NeuroAiD has shown favourable outcome in patients suffering from spinal cord injuries

* SATURN study aimed at assessing the safety and effects of a 6-month course of NeuroAiD (MLC601/...

2022-06-06 18:07 1764

NeuroAiD(TM)II holds promise as a safe add-on therapy to standard Alzheimer Disease symptomatic treatments and may have a disease modifying effect by delaying disease progression

SINGAPORE, Jan. 13, 2022 /PRNewswire/ -- Moleac is pleased to announce the release of the ATHENE st...

2022-01-13 12:32 2478

Moleac Announces US FDA Approval of IND Application for Phase 1 Study of MLC1501 Programme in Post-Traumatic Brain Injury Recovery

SINGAPORE, May 31, 2021 /PRNewswire/ -- Moleac, a biopharmaceutical company based inSingapore, anno...

2021-05-31 18:33 1522

Moleac Pte Ltd wins SBR National Business Award for Pharmaceuticals

SINGAPORE, May 6, 2021 /PRNewswire/ -- Moleac, a biopharmaceutical company based inSingapore, wins ...

2021-05-06 18:12 1735

Moleac Announces US FDA Approval of IND Application for Phase 1 Study of MLC1501 Programme in Post-Traumatic Brain Injury Recovery

SINGAPORE, April 14, 2021 /PRNewswire/ -- Moleac, a biopharmaceutical company based inSingapore, an...

2021-04-14 19:15 2007